Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jun 30, 2021
Date Accepted: Jul 6, 2021
Disability Inclusive Diabetes Self-Management Telehealth Program: A Protocol for a Pilot and Feasibility Study
ABSTRACT
Background:
Individuals with disabilities who have Type 2 diabetes need self-management programs that are accessible, sustainable, inclusive, and adaptable. Health coaching has been shown to be an effective approach in improving behavioral changes in self-management. Health coaching combined with telehealth technology has the potential to improve overall quality and access to health services.
Objective:
This protocol outlines the study design for implementing the Artificial Intelligence for Diabetes Management (AI4DM) intervention. The protocol will assess the feasibility, acceptability, and preliminary efficacy of the AI4DM telehealth platform for people with disabilities.
Methods:
The Artificial Intelligence for Diabetes Management (AI4DM) study is a two-arm randomized controlled trial evaluating the delivery of a 12-month intervention of telecoaching, diabetes educational content, and technology access in 90 individuals with diabetes and physical disabilities. The current hypothesis is that this pilot project is feasible and acceptable for adults with permanent impaired mobility and Type 2 diabetes. We also hypothesize that adults in the AI4DM intervention groups will result in significantly better glycemic control (glycated hemoglobin) and psychosocial and psychological measures than the attention control group at three-, six-, and twelve-month follow-ups.
Results:
The AI4DM study has been approved by the university’s Institutional Review Board and recruitment and enrollment is set to begin in August 2021.
Conclusions:
The AI4DM study will improve our understanding on the feasibility and efficacy of an online diabetes self-management program for people with disabilities. The AI4DM intervention has the potential to become a scalable and novel method to successfully manage Type 2 diabetes for people with disabilities. Clinical Trial: ClinicalTrials.gov: NCT04927377
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.